書誌情報
EPD65. Inhaled molgramostim for the treatment of autoimmune pulmonary alveolar proteinosis (aPAP) : Results from the IMPALA-2 phase 3 clinical trial
Yoshikazu Inoue1,2, Francesco Bonella3, Tisha Want4, Cormac McCarthy5, Bruce C.Trapnell6, Brian Robinson7, Rosanna Fleming7, Yasmine Wasfi7, Raymond Pratt7
1Clinical Research Center, NHO Kinki Chuo Chest Medical Center, 2Osaka Anti-tuberculosis Association, Osaka Fukujuji Hospital, 3Center for Interstitialand Rare Lung Diseases, Pneumology Dept., Ruhrlandklinik University Hospital, University of Duisburg-Essen, 4Div. of Pulmonary and Critical Care Medicine, University of California, 5School of Medicine, University College Dublin, St. Vincent's University Hospital, 6Translational Pulmonary Science Center, Cincinnati Children's Hospital, 7Medical, Savara Inc
Annals of The Japanese Respiratory Society 14(suppl): 361-361, 2025.
個人会員・法人会員の方（IDが5または10で始まる方）
- 全文ダウンロード： 従量制、基本料金制の方共に121円(税込) です。
